Ads
related to: Stage 4 Carcinoma Cancer and Cancer Patients
Search results
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoThe 925 participants in the open-label Phase... has been approved to treat a variety of cancers,...
Cancer diagnoses expected to increase by 77% by 2050
Dayton Daily News· 2 weeks agoCancer diagnoses are expected to increase 77% worldwide by 2050 and new trends in the occurrence of human papillomavirus amongcancer patients& ...
Is that mole melanoma? How to tell if a mole is cancerous or not
TODAY via Yahoo News· 7 days agoIf it turns out to be melanoma, your doctor may run blood tests and imaging scans to see how...
Tool May Help Prioritize High-Risk Patients for Hysteroscopy
Medscape· 2 weeks agoHysteroscopy is a crucial examination for the diagnosis of endometrial cancer. In Brazil, women with...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks· 17 hours agoThe phase III CheckMate -73L study evaluated Opdivo with concurrent chemoradiotherapy (CCRT) followed...CCRT followed by AstraZeneca’s (AZN Quick QuoteAZN - Free Report) Imfinzi (durvalumab) ...
Liver Cancer Screening Benefits Patients With Cirrhosis, Study Suggests
MedPage Today· 2 weeks agoScreening for hepatocellular carcinoma (HCC) in liver disease patients with cirrhosis may indeed lead to a survival benefit, a retrospective analysis of ...
'Just trying to attack this thing and be done with it,' how one Pueblo woman overcame breast cancer
KOAA5· 4 days agoMany cancer patients suffer hair loss while going through chemotherapy. One cancer survivor from Pueblo said her hair is a big part of ...
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX...
WKRN Nashville· 1 week agoThe trial is a randomized, placebo-controlled, double-blind Phase 2 study investigating the effect of setanaxib 800mg twice daily in conjunction with pembrolizumab 200mg IV, administered every ...
Routine Breast Cancer Screening Should Start at 40: USPSTF
Medscape· 2 weeks agoWomen who are considered to be at average risk for breast cancer should have mammograms every other...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 1 day agoFurther, the over-reliance...for Cabometyx include metastatic castration-resistant prostate cancer...
